PRD-ECAT-000001

PRD-ECAT-000001_2

Dotarem (gadoteric acid) 0.5mmol/mL

PRODUCT DESCRIPTION

Only ionic macrocyclic MRI contrast agent with high thermodynamic and kinetic stability
Excellent of all indications and demographics (newborn to elderly)
No unconfounded/consistent reports of NSF and no brain hypersignals is reported

Care Area
Diagnostic Imaging

Product Category
Consumables

PRINCIPAL

Inquire Now

Downloadables

1766_P16_228_DOT_-_Pediatric_brochure_bd

1832_P17_147_DOT_-_Comparison_of_Dotarem®_and_Gadovist®_in_the_MRI_Diagnosis_of_Primary_Brain_Tumors_bd

1891_P18_040_DOT_-_Stability_is_its_DNA_-_Product_Brochure_A4_(ex_P17_148_DOT)_bd

1901_P18_041_DOT_-_Gd_retention_brochure_-_21x21cm_(ex_P17_158_DOT)_bd

2015_Radbruch_Radiology783

A01 Guerbet flashcard D Dotarem 20180919

A02 Guerbet flashcard D Dotarem 20180919

Balassy 2015 preprint

De Kerviler invest Radiol 2016

De-Hua et al Safety of gadoterate meglimine in over 1600 children SECURE Acta radiol 2019

DOTA_2010_Ishiguchi & Takahashi

DOTA_2011_Maurer M_PMS 84,000 patients

Dotarem Dosage Chart

Dotarem Presentation

GUE-30Y_Dotarem_journey_v6_EXE_print

Intérieur monography DOTAREM UK P16 121 DOT -170516

REMIND study

Product Videos